All-trans-retinoic acid inhibits collapsin response mediator protein-2 transcriptional activity during SH-SY5Y neuroblastoma cell differentiation

FEBS Journal

Volumn 274, Issue 2, 2007, Pages 498-511

  Fontán Gabás, Lorena ^a   Oliemuller, Erik ^b   Martínez Irujo, Juan José ^a,b   De Miguel, Carlos ^a   Rouzaut, Ana ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

CRMP 2; Gene regulation; Neuroblastoma; Promoter; Retinoic acid

Indexed keywords

RETINOIC ACID; SEMAPHORIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR SP1;

ANALYTIC METHOD; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; MUTAGENESIS; NEUROBLASTOMA; PRIORITY JOURNAL; PROMOTER REGION;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE, TUMOR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NEUROBLASTOMA; PAIRED BOX TRANSCRIPTION FACTORS; PROMOTER REGIONS (GENETICS); RNA PROCESSING, POST-TRANSCRIPTIONAL; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION, GENETIC; TRETINOIN;

EID: 33846026704     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2006.05597.x     Document Type: Article

References (50)

1. Yamamoto N, Tamada A & Murakami F (2002) Wiring of the brain by a range of guidance cues. Prog Neurobiol 68, 393-407.
2. Goshima Y, Ito T, Sasaki Y & Nakamura F (2002) Semaphorins as signals for cell repulsion and invasion. J Clin Invest 109, 993-998.
3. Charrier E, Reibel S, Rogemond V, Aguera M, Thomasset N & Honnorat J (2003) Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders. Mol Neurobiol 28, 51-64.
4. Goshima Y, Nakamura F, Strittmatter P & Strittmatter SM (1995) Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 376, 509-514.
5. Fukata Y, Itoh TJ, Kimura T, Menager C, Nishimura T, Shiromizu T, Watanabe H, Inagaki N, Iwamatsu A, Hotani H et al. (2002) CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat Cell Biol 4, 583-591.
6. Inagaki N, Chihara K, Arimura N, Menager C, Kawano Y, Matsuo N, Nishimura T, Amano M & Kaibuchi K (2001) CRMP-2 induces axons in cultured hippocampal neurons. Nat Neurosci 4, 781-782.
7. Uchida Y, Ohshima T, Sasaki Y, Suzuki H, Yanai S, Yamashita N, Nakamura F, Takei K, Ihara Y, Mikoshiba K et al. (2005) Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Genes Cells 10, 165-179.
8. Yoshimura T, Kawano Y, Arimura N, Kawabata S, Kikuchi A & Kaibuchi K (2005) GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 120, 137-149.
9. Nishimura T, Fukata Y, Kato K, Yamaguchi T, Matsura Y, Kamiguchi H & Kaibuchi K (2003) CRMP-2 regulates polarized Numb-mediated endocytosis for axon growth. Nat Cell Biol 5, 819-826.
10. Arimura N, Menager C, Kawano Y, Yoshimura T, Kawabata S, Hattori A, Fukata Y, Amano M, Goshima Y, Inagaki M et al. (2005) Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones. Mol Cell Biol 25, 9973-9984.
11. Hamajima N, Matsuda K, Sakata S, Tamaki N, Sasaki M & Nonaka M (1996) A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution. Gene 180, 157-163.
12. Bretin S, Reibel S, Charrier E, Maus-Moatti M, Auvergnon N, Thevenoux A, Glowinski J, Rogemond V, Premont J, Honnorat J et al. (2005) Differential expression of CRMP1, CRMP2A, CRMP2B, and CRMP5 in axons or dendrites of distinct neurons in the mouse brain. J Comp Neurol 486, 1-17.
13. Lubec G, Nonaka M, Krapfenbauer K, Gratzer M, Cairns N & Fountoulakis M (1999) Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is down-regulated at the mRNA and dysregulated at the protein level. J Neural Transm Suppl 57, 161-177.
14. Beasley CL, Pennington K, Behan A, Wait R, Dunn MJ & Cotter D (2006) Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 6, 3414-3425.
15. Tahimic CG, Tomimatsu N, Nishigaki R, Fukuhara A, Toda T, Kaibuchi K, Shiota G, Oshimura M & Kurimasa A (2006) Evidence for a role of collapsin response mediator protein-2 in signalling pathways that regulate the proliferation of non-neuronal cells. Biochem Biophys Res Commun 340, 1244-1250.
16. Manohar CF, Salwen HR, Furtado MR & Cohn SL (1996) Up-regulation of HOXC6, HOXD1, and HOXD8 homeobox gene expression in human neuroblastoma cells following chemical induction of differentiation. Tumour Biol 17, 34-47.
17. Shih JY, Lee YC, Yang SC, Hong TM, Huang CY & Yang PC (2003) Collapsin response mediator protein-1: a novel invasion-suppressor gene. Clin Exp Metastasis 20, 69-76.
18. Antoine JC, Honnorat J, Camdessanche JP, Magistris M, Absi L, Mosnier JF, Petiot P, Kopp N & Michel D (2001) Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy. Ann Neurol 49, 214-221.
19. Reynolds CP & Lemons RS (2001) Retinoid therapy of childhood cancer. Hematol Oncol Clin North Am 15, 867-910.
20. Pijuan-Thompson V, Grammer JR, Stewart J, Silverstein RL, Pearce SF, Tuszynski GP, Murphy-Ullrich JE & Gladson CL (1999) Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1. Exp Cell Res 249, 86-101.
21. Butler R, Leigh PN & Gallo JM (2001) Androgen-induced up-regulation of tubulin isoforms in neuroblastoma cells. J Neurochem 78, 854-861.
22. Kitamura K, Takayama M, Hamajima N, Nakanishi M, Sasaki M, Endo Y, Takemoto T, Kimura H, Iwaki M & Nonaka M (1999) Characterization of the human dihydropyrimidinase-related protein 2 (DRP-2) gene. DNA Res 6, 291-297.
23. Quandt K, Frech K, Karas H, Wingender E & Werner T (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23, 4878-4884.
24. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M & Werner T (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21, 2933-2942.
25. Carter MG, Johns MA, Zeng X, Zhou L, Zink MC, Mankowski JL, Donovan DM & Baylin SB (2000) Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome. Hum Mol Genet 9, 413-419.
26. Roopra A, Huang Y & Dingledine R (2001) Neurological disease: listening to gene silencers. Mol Interv 4, 219-228.
27. Kurschat P, Bielenberg D, Rossignol-Tallandier M, Stahl A & Klagsbrun M (2006) Neuron restrictive silencer factor NRSF/REST is a transcriptional repressor of neuropilin-1 and diminishes the ability of semaphorin 3A to inhibit keratinocyte migration. J Biol Chem 281, 2721-2729.
28. Dimova DK & Dyson NJ (2005) The E2F transcriptional network: old acquaintances with new faces. Oncogene 24, 2810-2826.
29. Kaczynski J, Cook T & Urrutia R (2003) Sp1 and Kruppel-like transcription factors. Genome Biol 4, 206.
30. Kodama Y, Murakumo Y, Ichihara M, Kawai K, Shimono Y & Takahashi MY (2004) Induction of CRMP-2 by GDNF and analysis of the CRMP-2 promoter region. Biochem Biophys Res Commun 320, 108-115.
31. Williams T & Tjian R (1991) Analysis of the DNAbinding and activation properties of the human transcription factor AP-2. Genes Dev 5, 670-682.
32. Brewer S, Feng W, Huang J, Sullivan S & Williams T (2004) Wnt1-Cre-mediated deletion of AP-2alpha causes multiple neural crest-related defects. Dev Biol 267, 135-152.
33. Cho JH & Tsai MJ (2004) The role of BETA2/NeuroD1 in the development of the nervous system. Mol Neurobiol 30, 35-47.
34. López-Carballo G, Moreno L, Masia S, Perez P & Barettino D (2002) Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J Biol Chem 277, 25297-25304.
35. Reeves FC, Fredericks WJ, Rauscher FJ & Lillycrop KA (1998) The DNA binding activity of the paired box transcription factor Pax-3 is rapidly downregulated during neuronal cell differentiation. FEBS Lett 422, 118-122.
36. Mar L, Rivkin E, Kim DY, Yu JY & Cordes SP (2005) A genetic screen for mutations that affect cranial nerve development in the mouse. J Neurosci 25, 11787-11795.
37. Huang S, Jean D, Luca M, Tainsky MA & Bar-Eli M (1998) Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis. EMBO J 17, 4358-4369.
38. Batsche E, Muchardt C, Behrens J, Hurst HC & Cremisi C (1998) RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol Cell Biol 18, 3647-3658.
39. Haque N, Tanaka T, Iqbal K & Grundke-Iqbal I (1999) Regulation of expression, phosphorylation and biological activity of tau during differentiation in SY5Y cells. Brain Res 838, 69-77.
40. Haque N, Gong CX, Sengupta A, Iqbal K & Grundke-Iqbal I (2004) Regulation of microtubule-associated proteins, protein kinases and protein phosphatases during ATRA induced differentiation of SY5Y cells. Brain Res Mol Brain Res 129, 163-170.
41. Maschhoff KL & Baldwin HS (2000) Molecular determinants of neural crest migration. Am J Med Genet 97, 280-288.
42. Reeves FC, Burdge GC, Fredericks WJ, Rauscher FJ & Lillycrop KA (1999) Induction of antisense Pax-3 expression leads to the rapid morphological differentiation of neuronal cells and an altered response to the mitogenic growth factor bFGF. J Cell Sci 112, 253-261.
43. Hansford LM & Marshall GM (2005) Glial cell line-derived neurotrophic factor (GDNF) family ligands reduce the sensitivity of neuroblastoma cells to pharmacologically induced cell death, growth arrest and differentiation. Neurosci Lett 389, 77-82.
44. Williams T, Admon A, Luscher B & Tjian R (1988) Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev 2, 1557-1569.
45. Popa C, Dahler AL, Serewko-Auret MM, Wong CF, Smith L, Barnes LM, Strutton GM & Saunders NA (2004) AP-2 transcription factor family member expression, activity, and regulation in human epidermal keratinocytes in vitro. Differentiation 72, 185-197.
46. Dimberg A & Oberg F (2003) Retinoic acid-induced cell cycle arrest of human myeloid cell lines. Leuk Lymphoma 44, 1641-1650.
47. Harris RG, White E, Phillips ES & Lillycrop KA (2002) The expression of the developmentally regulated protooncogene Pax-3 is modulated by N-Myc. J Biol Chem 277, 34815-34825.
48. Schreiber E, Matthias P, Muller MM & Schaffner W (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 17, 6420.
49. Epstein JA, Shapiro DN, Cheng J, Lam PY & Maas RL (1996) Pax3 modulates expression of the c-Met receptor during limb muscle development. Proc Natl Acad Sci USA 93, 4213-4218.
50. Qiu Y, Guo M, Huang S & Stein R (2004) Acetylation of the BETA2 transcription factor by p300-associated factor is important in insulin gene expression. J Biol Chem 279, 9796-9802.